Sangamo Therapeutics Announces Second Quarter 2019 Conference Call and Webcast
July 31 2019 - 4:05PM
Business Wire
Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine
company, announced today that the Company will release its second
quarter 2019 financial results after the market closes on
Wednesday, August 7, 2019. The press release will be followed by a
conference call at 5:00 p.m. ET, which will be open to the public
via telephone and webcast. During the conference call, the Company
will review its financial results and provide a business
update.
The conference call dial-in numbers are (877) 377-7553 for
domestic callers and (678) 894-3968 for international callers. The
conference ID number for the call is 9582057. Participants may
access the live webcast via a link on the Sangamo Therapeutics
website in the Investors and Media section under Events and
Presentations. A conference call replay will be available for one
week following the conference call. The conference call replay
numbers for domestic and international callers are (855) 859-2056
and (404) 537-3406, respectively. The conference ID number for the
replay is 9582057.
About Sangamo Therapeutics
Sangamo Therapeutics, Inc. is focused on translating
ground-breaking science into genomic medicines with the potential
to transform patients' lives using gene therapy, ex vivo
gene-edited cell therapy, in vivo genome editing, and gene
regulation. For more information about Sangamo, visit
www.sangamo.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190731005772/en/
Investor Relations – Global McDavid
Stilwell 510-970-6000, x219 mstilwell@sangamo.com Media Inquiries – Global Aron Feingold
510-970-6000, x421 afeingold@sangamo.com Investor Relations and Media Inquiries – European Union
& United Kingdom Caroline Courme 33 4 97 21 27 27
ccourme@sangamo.com
Sangamo Therapeutics (NASDAQ:SGMO)
Historical Stock Chart
From Aug 2024 to Sep 2024
Sangamo Therapeutics (NASDAQ:SGMO)
Historical Stock Chart
From Sep 2023 to Sep 2024